Q1 2025 Novavax Inc Earnings Call Transcript

May 8, 2025 / 12:30 PM GMT

Transcript 8-K10-Q

Key Points

Positve

Novavax Inc (NVAX) reported a significant increase in total revenue for Q1 2025, reaching $667 million compared to $94 million in Q1 2024.
The company has successfully closed out agreements with Canada and New Zealand, recognizing $603 million in revenue from these terminations.
Novavax Inc (NVAX) is actively pursuing new partnerships and collaborations, including an expanded agreement with Takeda for the Japanese market.
The company is focused on optimizing its partnership with Sanofi, which includes potential milestones and royalties from new combination vaccines.
Novavax Inc (NVAX) is advancing its early-stage pipeline with four new programs and leveraging artificial intelligence and machine learning for R&D.

Negative

The company is still awaiting FDA approval for its COVID-19 vaccine BLA, with ongoing discussions about postmarketing commitments.
Novavax Inc (NVAX) has not yet secured a partner for the development and commercialization of its latest COVID-influenza combination vaccine.
The company's revenue framework for 2025 excludes potential additional revenue from Sanofi supply sales and other milestones, indicating uncertainty in future earnings.
There is a reliance on milestone payments and royalties from partners like Sanofi and Takeda, which may impact financial stability if not realized.
Novavax Inc (NVAX) is undergoing significant cost reductions and restructuring, which may affect its operational capabilities in the short term.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NVAX.OQ - Novavax Inc
Q1 2025 Novavax Inc Earnings Call
May 08, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Nova Back's first quarter 2025 financial results and operational highlights conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the start key followed by 0. After today's presentation, there will be an opportunity to ask the questions.

That's a question, you may press star, followed by the number 1 on your touchstone form. To withdraw your question, please press star, followed by the number 2. Please note, this event is being recorded.

I would now like to turn the conference over to Luis Sannai, Vice President, investor relations. Please go ahead.

---------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.